Kalaris Therapeutics, Inc. (KLRS)
3.17
+0.01
(+0.32%)
USD |
NASDAQ |
Sep 18, 16:00
3.20
+0.03
(+0.95%)
After-Hours: 20:00
Kalaris Therapeutics 30-Day Average Daily Volume : 54592.67 for Sept. 17, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 17, 2026 | 54592.67 |
| September 16, 2026 | 54028.17 |
| September 15, 2026 | 56425.10 |
| September 14, 2026 | 57999.50 |
| September 11, 2026 | 58476.60 |
| September 10, 2026 | 57849.37 |
| September 09, 2026 | 59155.93 |
| September 08, 2026 | 60332.57 |
| September 04, 2026 | 59364.37 |
| September 03, 2026 | 63827.60 |
| September 02, 2026 | 67084.63 |
| September 01, 2026 | 69754.37 |
| August 31, 2026 | 80856.03 |
| August 28, 2026 | 96817.40 |
| August 27, 2026 | 459864.9 |
| August 26, 2026 | 458413.6 |
| August 25, 2026 | 459950.7 |
| August 24, 2026 | 460256.7 |
| August 21, 2026 | 460811.2 |
| August 20, 2026 | 458445.8 |
| August 19, 2026 | 457308.1 |
| August 18, 2026 | 456809.3 |
| August 17, 2026 | 456572.3 |
| August 14, 2026 | 457224.3 |
| August 13, 2026 | 458164.3 |
| Date | Value |
|---|---|
| August 12, 2026 | 458095.5 |
| August 11, 2026 | 459489.6 |
| August 10, 2026 | 462638.9 |
| August 07, 2026 | 466786.7 |
| August 06, 2026 | 466598.2 |
| August 05, 2026 | 466429.8 |
| August 04, 2026 | 466286.3 |
| August 03, 2026 | 464041.1 |
| July 31, 2026 | 466672.9 |
| July 30, 2026 | 467023.3 |
| July 29, 2026 | 465984.4 |
| July 28, 2026 | 465448.7 |
| July 27, 2026 | 462647.9 |
| July 24, 2026 | 462259.5 |
| July 23, 2026 | 458595.8 |
| July 22, 2026 | 457462.0 |
| July 21, 2026 | 456147.4 |
| July 20, 2026 | 447682.8 |
| July 17, 2026 | 432386.8 |
| July 16, 2026 | 69105.37 |
| July 15, 2026 | 70386.60 |
| July 14, 2026 | 70088.43 |
| July 13, 2026 | 73741.33 |
| July 10, 2026 | 72809.60 |
| July 09, 2026 | 75207.10 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Replimune Group, Inc. | 3.257M |
| Arrowhead Pharmaceuticals, Inc. | 1.516M |
| Oncolytics Biotech, Inc. | 845959.6 |
| Sangamo Therapeutics, Inc. | 3.233M |
| Sarepta Therapeutics, Inc. | 3.013M |